Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalData Regulatory News (DATA)

Share Price Information for GlobalData (DATA)

Share Price is delayed by 15 minutes
Get Live Data
99.80    -3.60 (-3.48%)
Bid:
99.80
Ask:
100.40
Spread: 0.60 (0.601%)
Market Cap: £694.96m
DATA Live PriceLast checked at - London Stock Exchange

Intraday GlobalData Share Chart

Statement re Possible Offer

11 Jun 2025 07:10

RNS Number : 3642M
ICG Europe Fund IX GP S.a.r.l
11 June 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

 

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE").

 

FOR IMMEDIATE RELEASE.

 

11 June 2025

 

 

ICG Europe Fund IX GP S.a.r.l.[1]

 

Statement regarding GlobalData plc ("GlobalData")

 

Further to the announcements made by GlobalData on 30 April 2025, 28 May 2025 and 11 June 2025 regarding a possible offer for GlobalData, ICG Europe Fund IX GP S.a.r.l. on behalf of ICG Europe Fund IX SCSP1 ("ICG") confirms that it does not intend to make an offer for GlobalData.

 

This is a statement to which Rule 2.8 of the Code applies. Accordingly, ICG and any person(s) acting in concert with it will, except with the consent of the Panel on Takeovers and Mergers (the "Panel"), be bound by the restrictions set out in Rule 2.8 of the Code.

 

For the purposes of Rule 2.8 of the Code, ICG (and any person(s) acting in concert with it) reserves the right to set aside the restrictions in Rule 2.8 of the Code in any of the following circumstances: (i) with the agreement of the board of directors of GlobalData; (ii) following the announcement by or on behalf of a third party of a firm intention to make an offer for GlobalData; (iii) if GlobalData announces a Rule 9 waiver proposal (as described in Note 1 of the Notes on Dispensations from Rule 9 of the Code) or a reverse takeover (as defined in the Code); or (iv) if there has been a material change of circumstances (as determined by the Panel).

 

 

Enquiries:

 

ICG

Clare Glynn +44 (0)20 3545 1395

 

 

Important notices

 

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction, whether pursuant to this announcement or otherwise.

 

The release, distribution or publication of this announcement in jurisdictions outside the United Kingdom may be restricted by laws of the relevant jurisdictions and therefore persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

 


[1] ICG Europe Fund IX GP S.a.r.l. as general partner of ICG Europe Fund IX GP LP SCSp as general partner of ICG Europe Fund IX SCSP

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OFDQFLBFEQLBBBD
Date   Source Headline
24th Jan 20247:00 amRNSInvestor and Analyst Seminar
11th Jan 20247:00 amRNSTrading Update & Announcement of Investor Seminar
29th Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20237:00 amRNSInvestment in Healthcare Division by Inflexion
16th Nov 20237:00 amRNSDirector/PDMR Shareholding
13th Sep 202310:48 amRNSDirector/PDMR Shareholding
13th Sep 202310:41 amRNSDirector/PDMR Shareholding
8th Aug 20235:41 pmRNSDirector/PDMR Shareholding
8th Aug 20235:35 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSHalf Year Results
25th Jul 20232:58 pmRNSResults of General Meeting
7th Jul 20237:00 amRNSNotice of General Meeting
30th Jun 202310:00 amRNSDirector/PDMR Shareholding
25th Apr 20233:34 pmRNSResult of AGM
25th Apr 20237:00 amRNSAGM Trading Update and Notice of AI Seminar
29th Mar 20237:00 amRNSNotice of Annual General Meeting 2023
17th Mar 20236:02 pmRNSAnnual Report for year ended 31 December 2022
27th Feb 20237:00 amRNSFull Year Results
27th Jan 20234:31 pmRNSDirector/PDMR Shareholding
27th Jan 20234:26 pmRNSHolding(s) in Company
27th Jan 20239:28 amRNSDirector/PDMR Shareholding
24th Jan 20237:00 amRNSCapital Markets Day
18th Jan 202311:47 amRNSPDMR Dealing
10th Jan 20237:00 amRNSFull year trading update
10th Nov 20224:41 pmRNSSecond Price Monitoring Extn
10th Nov 20224:36 pmRNSPrice Monitoring Extension
17th Oct 20229:44 amRNSHoling(s) in Company
17th Oct 20228:44 amRNSHolding(s) in Company
14th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Sep 202210:59 amRNSHolding(s) in Company
2nd Sep 20227:00 amRNSCompletion of TS Lombard Acquisition
15th Aug 20227:00 amRNSDirector/PDMR Shareholding
15th Aug 20227:00 amRNS£82m Share Scheme Vests for 146 Employees
10th Aug 20227:00 amRNS£410million Debt Financing Facility
1st Aug 20227:00 amRNSHalf Year Results
20th Jul 20227:00 amRNSAppointment of Joint Broker
15th Jul 20227:00 amRNSNotice of Interim Results
28th Jun 202212:45 pmRNSAnnual Report FY2021
26th Apr 202212:32 pmRNSResults of AGM
4th Apr 20221:14 pmRNSNotice of AGM
28th Feb 20227:00 amRNSFinal Year Results
24th Feb 20227:00 amRNSHolding(s) in Company
14th Jan 20224:43 pmRNSPDMR Notification
10th Jan 20227:00 amRNSUpdate on FY21 performance and Capital Markets Day
15th Dec 20217:00 amRNSAcquisition of Automotive and Agribusiness Assets
9th Sep 20217:00 amRNSAcquisition of Life Sciences business
28th Jul 20219:09 amRNSPDMR Notification
26th Jul 20217:00 amRNSUnaudited interim report
2nd Jul 202112:27 pmRNSInterim Accounts
24th Jun 202110:37 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.